Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

12.03
-0.3200-2.59%
Post-market: 12.030.00000.00%19:30 EDT
Volume:348.05K
Turnover:4.20M
Market Cap:421.86M
PE:-100.25
High:12.42
Open:12.35
Low:11.88
Close:12.35
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:1.04
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.94
PE(LYR):-35.29

Loading ...

Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Major Issues Report

Form 8-K - Current report